Skip to content
10-Q

Quarterly Report

KYTHERA BIOPHARMACEUTICALS INC

0001104659-15-035576

← back to feed
Filed
May 7, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · Apr 6, 2015 25.81M sh
Capex Q1 2015 · Mar 31, 2015 $268K
Capex Q1 2015 · Mar 31, 2014 $42K
Cash And Equivalents Q1 2015 · Mar 31, 2015 $165.87M
Cash And Equivalents Q1 2015 · Dec 31, 2014 $29.23M
Cash And Equivalents Q1 2015 · Mar 31, 2014 $93.17M
Cash And Equivalents Q1 2015 · Dec 31, 2013 $111.52M
Stockholders Equity Q1 2015 · Mar 31, 2015 $170.67M
Stockholders Equity Q1 2015 · Dec 31, 2014 $59.44M
Current Liabilities Q1 2015 · Mar 31, 2015 $19.54M
Current Liabilities Q1 2015 · Dec 31, 2014 $20.63M
Total Liabilities Q1 2015 · Mar 31, 2015 $44.63M
Total Liabilities Q1 2015 · Dec 31, 2014 $43.99M
Current Assets Q1 2015 · Mar 31, 2015 $212.95M
Current Assets Q1 2015 · Dec 31, 2014 $101.16M
Total Assets Q1 2015 · Mar 31, 2015 $215.3M
Total Assets Q1 2015 · Dec 31, 2014 $103.43M
Sga Expense Q1 2015 · Mar 31, 2015 $12.5M
Sga Expense Q1 2015 · Mar 31, 2014 $6.12M
Rd Expense Q1 2015 · Mar 31, 2015 $15.27M
Rd Expense Q1 2015 · Mar 31, 2014 $9.98M
Net Income Q1 2015 · Mar 31, 2015 −$28.81M
Net Income Q1 2015 · Mar 31, 2014 −$69.45M
Operating Income Q1 2015 · Mar 31, 2015 −$27.76M
Operating Income Q1 2015 · Mar 31, 2014 −$68.86M